Onno W. Akkerman
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology 57
- Molecular Medicine top 5%
- Epidemiology top 5%
- Mycobacterium research and diagnosis 18
- Pneumonia and Respiratory Infections 18
- Pneumocystis jirovecii pneumonia detection and treatment 14
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 23
-
- Cystic Fibrosis Research Advances 13
- Inhalation and Respiratory Drug Delivery 9
-
- Infectious Diseases and Tuberculosis 13
- Co-authors
- Jan‐Willem C. AlffenaarTjip S. van der WerfMathieu S. BolhuisSimon TiberiDaan J. TouwMarieke G. G. SturkenboomHenderik W. FrijlinkDick van Soolingen
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (6 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- NetherlandsUnited KingdomAustralia
In The Last Decade
Onno W. Akkerman
95 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 747
- Molecular Medicine 107
- Epidemiology 551
- Pharmacology 255
- Applied Microbiology and Biotechnology 27
Countries citing papers authored by Onno W. Akkerman
This map shows the geographic impact of Onno W. Akkerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Onno W. Akkerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Onno W. Akkerman more than expected).
Fields of papers citing papers by Onno W. Akkerman
This network shows the impact of papers produced by Onno W. Akkerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Onno W. Akkerman. The network helps show where Onno W. Akkerman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Onno W. Akkerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 6 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 12 | |
| 15 | 2020 | 21 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 10 | |
| 18 | 2018 | 18 | |
| 19 | 2016 | 10 | |
| 20 | 2016 | 32 |
About Onno W. Akkerman
Onno W. Akkerman is a scholar working on Infectious Diseases, Molecular Medicine and Pharmacology, having authored 102 papers that have together received 1.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (57 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers), Mycobacterium research and diagnosis (18 papers), Pneumonia and Respiratory Infections (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers), Cystic Fibrosis Research Advances (13 papers), Infectious Diseases and Tuberculosis (13 papers) and Inhalation and Respiratory Drug Delivery (9 papers). The work is most often cited by research in Infectious Diseases (747 citations), Molecular Medicine (107 citations) and Epidemiology (551 citations). Onno W. Akkerman has collaborated with scholars based in Netherlands, United Kingdom and Australia. Frequent co-authors include Jan‐Willem C. Alffenaar, Tjip S. van der Werf, Mathieu S. Bolhuis, Simon Tiberi, Daan J. Touw, Marieke G. G. Sturkenboom, Henderik W. Frijlink, Dick van Soolingen, Jos G. W. Kosterink and Wiel C.M. de Lange. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.